# Jeff Terrell

> Jeff Terrell is a Series A investor at Hatteras Venture Partners backing Health Care and Medical. See 10 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Hatteras Venture Partners](https://shizune.co/investors/profile/hatteras-venture-partners)
- Location: Durham, United States
- Total investments: 10
- Last investment: Feb 2026
- Lead investor: 80%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/pub/jeff-terrell/4/5a2/a51

Jeff Terrell is a Partner at Hatteras Venture Partners and was a Clinical Specialist and Associate Sales Rep - Medicraft at Medtronic. He attended Duke University - The Fuqua School of Business and Princeton University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 5 | 50% |
| Medical | 3 | 30% |
| Medical Device | 3 | 30% |
| SaaS | 1 | 10% |
| Hospital | 1 | 10% |

14 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 4 | 40% |
| Series B | 3 | 30% |
| Series C | 1 | 10% |
| Funding Round | 1 | 10% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Pharaoh Neuro | Pharaoh Neuro develops a neurapheresis cerebrospinal fluid management system for neurological patients. | $20M | Series A | Feb 18, 2026 |  |
| Boomerang Medical | Boomerang Medical is a female-led bioelectronic medical technology firm that is revolutionizing the management of autoimmune illnesses. | $20M | Series B | Sep 04, 2025 |  |
| 410 Medical | 410 Medical has developed a simple, intuitive solution that allows a single healthcare provider to rapidly deliver fluid to critically ill patients, improving care, and saving lives. Their device allows fast set-up, improves resuscitation speed, minimizes provider fatigue, and frees providers to address other patient care issues simultaneously.This solution is particularly useful in pre-hospital settings and the emergency department and where speed is critical and resources may be limited.It was founded in 2013 and headquartered in Durham, North Carolina. | $14M | Series B | Mar 17, 2025 |  |
| AtaCor Medical | AtaCor Medical Inc., is a San Clemente-based medical device maker. It designs innovative solutions to deliver temporary, interim, and permanent cardiac pacing when, and where it matters most. | $28M | Series C | Apr 24, 2024 |  |
| 410 Medical | 410 Medical has developed a simple, intuitive solution that allows a single healthcare provider to rapidly deliver fluid to critically ill patients, improving care, and saving lives. Their device allows fast set-up, improves resuscitation speed, minimizes provider fatigue, and frees providers to address other patient care issues simultaneously.This solution is particularly useful in pre-hospital settings and the emergency department and where speed is critical and resources may be limited.It was founded in 2013 and headquartered in Durham, North Carolina. | $7.5M | Series B | May 25, 2023 |  |
| Cardiosense | Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease. | $15.1M | Series A | Dec 08, 2022 |  |
| Boomerang Medical | Boomerang Medical is a female-led bioelectronic medical technology firm that is revolutionizing the management of autoimmune illnesses. | $15M | Series A | Nov 01, 2022 |  |
| AtaCor Medical | AtaCor Medical Inc., is a San Clemente-based medical device maker. It designs innovative solutions to deliver temporary, interim, and permanent cardiac pacing when, and where it matters most. | $25M | Series B | Apr 28, 2020 |  |
| 410 Medical | 410 Medical has developed a simple, intuitive solution that allows a single healthcare provider to rapidly deliver fluid to critically ill patients, improving care, and saving lives. Their device allows fast set-up, improves resuscitation speed, minimizes provider fatigue, and frees providers to address other patient care issues simultaneously.This solution is particularly useful in pre-hospital settings and the emergency department and where speed is critical and resources may be limited.It was founded in 2013 and headquartered in Durham, North Carolina. |  | Series A | Oct 22, 2019 |  |
| NurseGrid | Founded by nurses and technology entrepreneurs, NurseGrid makes integrated, intuitive staffing and communication tools just for nurses and nursing departments. NurseGrid has two products: NurseGrid Mobile & NurseGrid Manager.NurseGrid Mobile is the easiest way for nurses and healthcare workers to manage their complex schedules, connect withcolleagues, and bring more balance to their work lives. More than 300,000 nurses have downloaded NurseGrid to date and the iOS app enjoys a consistent 5 star average rating on the App Store.NurseGrid Manager allows nursing departments to simplify team communication, staffing, and schedule management, making staff and managers happier and more productive. It complements core scheduling systems such as Kronos, API, and McKesson, filling in the critical gap current technologies leave between schedule creation and timekeeping, and giving nurse leaders a cost-saving, nurse-preferred way to manage day to day staffing and scheduling needs.NurseGrid was launched in 2013. | $5.7M |  | Jan 18, 2018 |  |

10 of 10 investments shown.

## Co-investors
- [Arboretum Ventures](https://shizune.co/investors/profile/arboretum-ventures) — VC Fund, 3 deals together
- [OSF Healthcare System](https://shizune.co/investors/profile/osf) — VC Fund, 3 deals together
- [Ballad Ventures](https://shizune.co/investors/profile/ballad-ventures) — VC Fund, 2 deals together
- [Broadview Ventures](https://shizune.co/investors/profile/broadview-ventures) — VC Fund, 2 deals together
- [Catalyst Health Ventures](https://shizune.co/investors/profile/catalyst-health-ventures) — VC Fund, 2 deals together
- [Laerdal Million Lives Fund](https://shizune.co/investors/profile/laerdal-million-lives-fund) — VC Fund, 2 deals together

## About Hatteras Venture Partners

VC Fund · Durham, United States

Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC, with a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine. Founded in 2000, the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to buildingsuccessful new biomedical companies. The Hatteras Venture Partners team brings operational experience, a successful track record, and a proven ability to enhance the value of the companies in which it invests. With three funds, the firm has more than $120 million under management.

5 contacts available at Hatteras Venture Partners.

| Name | Title | Profile |
| --- | --- | --- |
| Douglas Reed | General Partner | https://shizune.co/investors/profile/douglas-reed |
| Jeff Terrell | General Partner | https://shizune.co/investors/profile/jeff-terrell |
| Myla Lai-Goldman | Venture Partner | https://shizune.co/investors/profile/myla-lai-goldman |
| Christy L. Shaffer | General Partner | https://shizune.co/investors/profile/christy-l-shaffer |
| Clay B. Thorp | General Partner and Co-Founder | https://shizune.co/investors/profile/clay-b-thorp |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Jeff Terrell invest in?

Jeff Terrell invests primarily in Health Care, Medical and Medical Device startups, most often at Series A and Series B stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jeff Terrell last invest?

The most recent investment recorded for Jeff Terrell closed in Feb 2026. Shizune tracks 10 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co